HeartSciences Inc has a consensus price target of $7.33 based on the ratings of 4 analysts. The high is $15 issued by Ascendiant Capital on September 23, 2024. The low is $3 issued by Maxim Group on December 19, 2022. The 3 most-recent analyst ratings were released by Ascendiant Capital, Ascendiant Capital, and Maxim Group on September 23, 2024, January 30, 2023, and December 19, 2022, respectively. With an average price target of $7.1 between Ascendiant Capital, Ascendiant Capital, and Maxim Group, there's an implied 167.92% upside for HeartSciences Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for HeartSciences (NASDAQ:HSCS) was reported by Ascendiant Capital on September 23, 2024. The analyst firm set a price target for $15.00 expecting HSCS to rise to within 12 months (a possible 466.04% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for HeartSciences (NASDAQ:HSCS) was provided by Ascendiant Capital, and HeartSciences reiterated their buy rating.
There is no last upgrade for HeartSciences
There is no last downgrade for HeartSciences.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HeartSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HeartSciences was filed on September 23, 2024 so you should expect the next rating to be made available sometime around September 23, 2025.
While ratings are subjective and will change, the latest HeartSciences (HSCS) rating was a reiterated with a price target of $15.00 to $15.00. The current price HeartSciences (HSCS) is trading at is $2.65, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.